arrow
H

Hirotaka Konishi

Kyoto Prefectural University of Medicine
H指数:47
被引数:7,961

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Prognostic Significance and Clinical Robustness of the HALP Score in Super-Elderly Patients Undergoing Curative Gastrectomy for Gastric Cancer: A Multicenter Retrospective Cohort Study

超高龄胃癌患者根治性胃切除术的HALP评分的预后意义和临床稳健性:一项多中心回顾性队列研究

2026-10-250
OA
Lymphadenectomy through a triple-instrument cervical approach: a technical advance in single-port mediastinoscopic radical esophagectomy for esophageal cancer

经三器械颈部入路的淋巴结清扫术:单孔纵隔镜下食管癌根治性食管切除术的技术进步

2025-12-010
PRE
Surgical strategy for laparoscopic right posterior sectionectomy and segmentectomies of segments VII and VIII, considering the courses of P6a and the right hepatic vein

腹腔镜右后叶切除术及VII、VIII段肝段切除术的手术策略,考虑P6a和右肝静脉的走行

2025-12-010
PRE
ASO Visual Abstract: Survival Benefit of Adjuvant S-1 Chemotherapy in Patients Aged ≥ 80 Years with Gastric Cancer after Curative Resection—A Multicenter Cohort Study

ASO视觉摘要:≥80岁胃癌根治性切除术后辅助S-1化疗的生存获益——一项多中心队列研究

2025-10-170
PRE
Survival Benefit of Adjuvant S-1 Chemotherapy in Patients Aged ≥ 80 Years with Gastric Cancer after Curative Resection: A Multicenter Cohort Study

≥ 80岁胃癌患者根治术后辅助S-1化疗的生存获益:一项多中心队列研究

2025-09-240
PRE
ASO Visual Abstract: Evaluation of Exosome-Based Delivery of Tumor-Suppressive microRNAs for Novel Therapy in Peritoneal Dissemination of Gastric Cancer: Evidence from Experimental Animal Models

ASO视觉摘要:基于外泌体的肿瘤抑制microRNAs在胃癌腹膜播散新型疗法中的递送评估:实验动物模型的证据

2025-08-290
PRE
Evaluation of Exosome-Based Delivery of Tumor-Suppressive microRNAs for Novel Therapy in Peritoneal Dissemination of Gastric Cancer: Evidence from Experimental Animal Models

基于外泌体的肿瘤抑制性microRNAs在胃癌腹膜播散的新型治疗中的递送评估:实验动物模型的证据

2025-07-250
PRE
Development of IKOMAP Formulas for Determining Appropriate Liver Transection Line in Ultrasound-Guided Minimally Invasive Partial Hepatectomy Considering Liver Inclination

基于肝脏倾斜考虑,开发用于超声引导下微创部分肝切除术确定合适肝切线的IKOMAP公式

2025-07-170
PRE
Prognostic value of liver metastasis in patients with esophageal squamous cell carcinoma treated with nivolumab

接受nivolumab治疗的食管鳞状细胞癌患者中,肝转移的预后价值

2025-01-170
OA
Real-world effectiveness and safety of trastuzumab-deruxtecan in Japanese patients with HER2-positive advanced gastric cancer (EN-DEAVOR study) ( oct , 10.1007/s10120-024-01555-w , 2024)

曲妥珠单抗-deruxtecan在日本HER2-positive晚期胃癌患者中的真实世界有效性和安全性 (EN-DEAVOR研究) (10月,10.1007/s10120-024-01555-w,2024)

2024-11-280
OAAI
Real-world effectiveness and safety of trastuzumab-deruxtecan in Japanese patients with HER2-positive advanced gastric cancer (EN-DEAVOR study)

曲妥珠单抗-deruxtecan在日本HER2-positive晚期胃癌患者中的真实世界有效性和安全性 (EN-DEAVOR研究)

2024-10-102
OAAI